Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | carboxylesterase | 0.0061 | 0.0052 | 0.0052 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Brugia malayi | Carboxylesterase family protein | 0.0061 | 0.0052 | 0.0052 |
Brugia malayi | Carboxylesterase family protein | 0.0359 | 0.2917 | 0.2917 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0048 | 0.0048 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0061 | 0.0052 | 0.0179 |
Schistosoma mansoni | acetylcholinesterase | 0.0061 | 0.0052 | 0.0179 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0061 | 0.0052 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0359 | 0.2917 | 1 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Onchocerca volvulus | 0.0061 | 0.0052 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0359 | 0.2917 | 0.2917 |
Loa Loa (eye worm) | hypothetical protein | 0.1097 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Loa Loa (eye worm) | hypothetical protein | 0.0359 | 0.2917 | 0.2917 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Loa Loa (eye worm) | hypothetical protein | 0.0359 | 0.2917 | 0.2917 |
Leishmania major | C-8 sterol isomerase-like protein | 0.1097 | 1 | 0.5 |
Onchocerca volvulus | 0.0061 | 0.0052 | 0.5 | |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.1097 | 1 | 0.5 |
Onchocerca volvulus | 0.0061 | 0.0052 | 0.5 | |
Onchocerca volvulus | 0.0061 | 0.0052 | 0.5 | |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Loa Loa (eye worm) | hypothetical protein | 0.0561 | 0.4852 | 0.4852 |
Schistosoma mansoni | gliotactin | 0.0061 | 0.0052 | 0.0179 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0048 | 0.0048 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Echinococcus multilocularis | acetylcholinesterase | 0.0359 | 0.2917 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0061 | 0.0052 | 0.5 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0359 | 0.2917 | 0.2917 |
Brugia malayi | Carboxylesterase family protein | 0.0061 | 0.0052 | 0.0052 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Brugia malayi | Carboxylesterase family protein | 0.0061 | 0.0052 | 0.0052 |
Brugia malayi | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0048 | 0.0048 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0061 | 0.0052 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0359 | 0.2917 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0359 | 0.2917 | 1 |
Onchocerca volvulus | 0.0061 | 0.0052 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0061 | 0.0052 | 0.0052 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0061 | 0.0052 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0052 | 0.0052 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0061 | 0.0052 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0048 | 0.0048 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0061 | 0.0052 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0359 | 0.2917 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.1097 | 1 | 0.5 |
Echinococcus granulosus | neuroligin | 0.0061 | 0.0052 | 0.0179 |
Echinococcus multilocularis | neuroligin | 0.0061 | 0.0052 | 0.0179 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0061 | 0.0052 | 0.0179 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Loa Loa (eye worm) | carboxylesterase | 0.0359 | 0.2917 | 0.2917 |
Echinococcus granulosus | acetylcholinesterase | 0.0359 | 0.2917 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0061 | 0.0052 | 0.0052 |
Echinococcus granulosus | carboxylesterase 5A | 0.0359 | 0.2917 | 1 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0061 | 0.0052 | 0.0179 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0061 | 0.0052 | 0.0179 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0061 | 0.0052 | 0.0179 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.